日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interpretable inflammation landscape of circulating immune cells

循环免疫细胞的可解读炎症图谱

Jiménez-Gracia, Laura; Maspero, Davide; Aguilar-Fernández, Sergio; Craighero, Francesco; Boulougouri, Maria; Ruiz, Max; Marchese, Domenica; Caratù, Ginevra; Liñares-Blanco, Jose; Berasategi, Miren; Ramirez Flores, Ricardo O; Sanzo-Machuca, Angela; Corraliza, Ana M; Tran, Hoang A; Normand, Rachelly; Nestor, Jacquelyn; Hong, Yourae; Kole, Tessa; van der Velde, Petra; Alleblas, Frederique; Pedretti, Flaminia; Aterido, Adrià; Banchero, Martin; Soriano, German; Román, Eva; van den Berge, Maarten; Salas, Azucena; Carrascosa, Jose Manuel; Fernández Nebro, Antonio; Domènech, Eugeni; Cañete, Juan D; Tornero, Jesús; Gisbert, Javier P; Choy, Ernest; Girolomoni, Giampiero; Siegmund, Britta; Julià, Antonio; Serra, Violeta; Elosua, Roberto; Tejpar, Sabine; Vidal, Silvia; Nawijn, Martijn C; Gut, Ivo; Saez-Rodriguez, Julio; Marsal, Sara; Villani, Alexandra-Chloé; Nieto, Juan C; Heyn, Holger

Publisher Correction: Interpretable inflammation landscape of circulating immune cells

出版商更正:循环免疫细胞的可解释炎症图谱

Jiménez-Gracia, Laura; Maspero, Davide; Aguilar-Fernández, Sergio; Craighero, Francesco; Boulougouri, Maria; Ruiz, Max; Marchese, Domenica; Caratù, Ginevra; Liñares-Blanco, Jose; Berasategi, Miren; Ramirez Flores, Ricardo O; Sanzo-Machuca, Angela; Corraliza, Ana M; Tran, Hoang A; Normand, Rachelly; Nestor, Jacquelyn; Hong, Yourae; Kole, Tessa; van der Velde, Petra; Alleblas, Frederique; Pedretti, Flaminia; Aterido, Adrià; Banchero, Martin; Soriano, German; Román, Eva; van den Berge, Maarten; Salas, Azucena; Carrascosa, Jose Manuel; Fernández Nebro, Antonio; Domènech, Eugeni; Cañete, Juan D; Tornero, Jesús; Gisbert, Javier P; Choy, Ernest; Girolomoni, Giampiero; Siegmund, Britta; Julià, Antonio; Serra, Violeta; Elosua, Roberto; Tejpar, Sabine; Vidal, Silvia; Nawijn, Martijn C; Gut, Ivo; Saez-Rodriguez, Julio; Marsal, Sara; Villani, Alexandra-Chloé; Nieto, Juan C; Heyn, Holger

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

同源重组缺陷和半合子状态是乳腺癌耐药性的驱动因素

Safonov, Anton; Lee, Minna; Brown, David N; Boscolo Bielo, Luca; Mehine, Miika; Bandlamudi, Chaitanya; O'Leary, Ben; Shao, Hong; Vicente, Laia; Muldoon, Daniel; Zhu, Allen; Ros, Susana; Marra, Antonio; Selenica, Pier; Bieche, Ivan; Wubbenhorst, Bradley; Ferraro, Emanuela; Courtois, Laura; El Botty, Rania; Ahmed, Mehnaj; Moiso, Enrico; An, Julia Ah-Reum; Donoghue, Mark T A; Will, Marie; Pareja, Fresia; Nizialek, Emily; Lukashchuk, Natalia; Sofianopoulou, Eleni; Liu, Yuan; Huang, Xin; Chappey, Colombe; Staniszewska, Anna D; Ross, Dara; Mandelker, Diana; Ladanyi, Marc; Schultz, Nikolaus; Berger, Michael F; Scaltriti, Maurizio; Reis-Filho, Jorge S; Li, Bob T; Offit, Kenneth; Norton, Larry; Shen, Ronglai; Maxwell, Kara N; Couch, Fergus; Domchek, Susan M; Marangoni, Elisabetta; Shah, Sohrab; Albertella, Mark R; Serra, Violeta; Weigelt, Britta; Solit, David B; Nathanson, Katherine L; Robson, Mark E; Turner, Nicholas C; Chandarlapaty, Sarat; Razavi, Pedram

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51 同源重组缺陷与早期乳腺癌的治疗反应和生存率相关。

Llop-Guevara Alba, Pellegrino Benedetta, Pimentel Isabel, Villacampa Guillermo, Solinas Cinzia, Torres-Esquius Sara, Campanini Nicoletta, Simonetti Sara, Tommasi Chiara, Serra Olga, Corianò Matilde, Boggiani Daniela, Michiara Maria, Minari Roberta, Bortesi Beatrice, Rapacchi Elena, Dieci Maria Vittoria, Lambertini Matteo, Zoppoli Gabriele, Schirone Alessio, Casarini Chiara, Cretella Elisabetta, Cortesi Laura, Silini Enrico Maria, Saura Cristina, Willard-Gallo Karen, Boisson Anais, Musolino Antonino, Serra Violeta, Balmaña Judith, Cruz Cristina

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

USP10/GSK3β介导的PTEN抑制导致乳腺癌对PI3K抑制剂产生耐药性

Kumari, Nishi; Wright, Sarah Ce; Witham, Christopher M; Monserrat, Laia; Palafox, Marta; Richard, John Lc; Costa, Carlotta; Elkabets, Moshe; Agostino, Mark; Klemm, Theresa; Eccles, Melissa; Garnham, Alex; Wu, Ting; Nilsson, Jonas A; Walz, Nikita; Venugopal, Veena; Cerra, Anthony; Vasilevski, Natali; Bridgeman, Stephanie; Bassi, Sona; Saei, Azad; Helal, Moutaz; Neundorf, Philipp; Riedel, Angela; Rosenfeldt, Mathias; Gill, Jespal; Pahor, Nikolett; Hartmann, Oliver; Chung, Jacky; Sidhu, Sachdev S; Moderau, Nina; Jha, Sudhakar; Rodon, Jordi; Diefenbacher, Markus E; Komander, David; Serra, Violeta; Eichhorn, Pieter Johan Adam

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.

磷酸化RPA2可预测同源重组功能正常的卵巢癌对铂类和PARP抑制剂的反应

Schab Angela, Compadre Amanda, Drexler Rebecca, Loeb Megan, Rodriguez Kevin, Brill Joshua, Harrington Shariska, Sandoval Carmen, Sanders Brooke, Kuroki Lindsay, McCourt Carolyn, Hagemann Andrea R, Thaker Premal, Mutch David, Powell Matthew, Serra Violeta, Hagemann Ian S, Walts Ann E, Karlan Beth Y, Orsulic Sandra, Fuh Katherine C, Sun Lulu, Verma Priyanka, Lomonosova Elena, Zhao Peinan, Khabele Dineo, Mullen Mary M

Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts

乳腺癌患者来源异种移植模型中帕妥珠单抗德鲁替康长期疗效的决定因素

Òdena, Andreu; Monserrat, Laia; Brasó-Maristany, Fara; García-Galea, Eduardo; Casals, Eloi; Molina, Cristina; Herencia-Ropero, Andrea; Pedretti, Flaminia; Domènech, Heura; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Esteve-Codina, Anna; Dienstmann, Rodrigo; Chandarlapaty, Sarat; Fan, Pang-Dian; Suto, Fumitaka; Oliveira, Mafalda; Prat, Aleix; Serra, Violeta

Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer.

联合疗法克服了 ATM 缺陷型前列腺癌的继发性 PARPi 耐药性。

Arce-Gallego Sara, Esquefa Victor, Domenech Heura, Salca Andrei, Aguilar Daniel, Casals Teresa, Mir Gisela, Simonetti Sara, Oliveira Anna, de Llobet Lara, Neeb Antje, Brandariz Julian, Anselmino Nicolas, Casanova-Salas Irene, Herranz Nicolas, Serra Violeta, de Bono Johann S, Mateo Joaquin

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial

来自PARSIFAL试验的激素受体阳性晚期乳腺癌患者帕博西尼疗效的生物标志物

Albanell, Joan; Pozo, Angelo Gámez; Arteaga, Carlos L; Bellet, Meritxell; Rojo, Federico; González, Abel; Bellosillo, Beatriz; Serra, Violeta; Gener, Petra; Guerrero, José Antonio; Shimizu, Eileen; Mancino, Mario; Rodríguez-Morató, Jose; Mina, Leonardo; Pérez-García, José Manuel; Cortés, Javier; Llombart-Cussac, Antonio

MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer.

Omomyc 通过抑制 MYC 导致 DNA 损伤,从而克服乳腺癌中的 PARPi 耐药性。

Giuntini Fabio, González-Larreategui Íñigo, Herencia-Ropero Andrea, Casacuberta-Serra Silvia, Zacarías-Fluck Mariano F, Arnal Magdalena, Pedretti Flaminia, Martínez-Martín Sandra, Thabussot Hugo, Cano Virginia Castillo, Grueso Judit, Foradada Laia, Serrano Erika, López-Estévez Sergio, Rodriguez Olga, Guzman Marta, Rodriguez-Hernandez Adela, Brasó-Maristany Fara, Llop-Guevara Alba, Balmaña Judith, Nonell Lara, Prat Aleix, Serra Violeta, Beaulieu Marie-Eve, Whitfield Jonathan R, Massó-Vallés Daniel, Soucek Laura